| http://www.w3.org/ns/prov#value | - Initially Enterome is using its expertise and proprietary technologies to develop novel diagnostic products to support patient stratification personalized therapies and the clinical development of new drugs for the treatment of microbiome-related diseases such as inflammatory bowel diseases and metabolic diseases (diabetes and obesity).
|
